Dupilumab is very effective in a large cohort of difficult‐to‐treat adult atopic dermatitis patients: First clinical and biomarker results from the BioDay registry
Ariëns, Lieneke FM, van der Schaft, Jorien, Bakker, Daphne S, Balak, Deepak, Romeijn, Margreet LE, Kouwenhoven, Tessa, Kamsteeg, Marijke, Giovannone, Barbara, Drylewicz, Julia, van Amerongen, Cynthia,Журнал:
Allergy
DOI:
10.1111/all.14080
Date:
October, 2019
Файл:
PDF, 1019 KB
2019
File converter
Більше результатів пошуку
More benefits 
